肯尼亚的莱什曼病:一个范围审查
Grace Grifferty1,2, Hugh Shirley2,3, Katherine O'Brien2,4
1Department of Cellular and Molecular Biology, College of Science, Northeastern University, Boston, Massachusetts, United States of America.
PLoS neglected tropical diseases
|June 1, 2023
概括
肯尼亚的莱什曼病研究已经过时,对预防,共感染和不太常见的形式如MCL和PKDL的关注很少. 更新的研究工作对于控制这些被忽视的热带疾病至关重要.
科学领域:
- 被忽视的热带疾病被忽视的热带疾病
- 寄生虫学的寄生虫学
- 公共卫生 公共卫生
背景情况:
- 莱什曼尼亚病是由莱什曼尼亚寄生虫引起的载体传播疾病,影响全球16亿人.
- 有四种主要类型:内脏莱什曼病 (VL),皮肤莱什曼病 (CL),粘膜皮肤莱什曼病 (MCL) 和卡拉阿扎尔后皮肤莱什曼病 (PKDL).
- 肯尼亚的莱什曼病研究缺乏系统的描述,阻碍了有针对性的干预.
研究的目的:
- 系统地描述肯尼亚莱什曼病研究的现状.
- 确定肯尼亚莱什曼病研究中现有的研究差距.
- 为未来的莱什曼病控制研究和干预策略提供信息.
主要方法:
- 使用系统审查和元分析 (PRISMA) 方法的首选报告项目进行系统审查和系统审查.
- 搜索了七个在线数据库,查找到2022年1月之前发表的关于肯尼亚莱什曼病的文章.
- 根据研究类型,重点和出版期,分析了269篇符合条件的文章.
主要成果:
- 大多数研究集中在VL (52%) 上,在1980-1994年间发表 (39%).
- 主要研究主题包括"载体" (34%),"流行病学研究" (33%) 和"临床研究" (33%).
- 在MCL (1%) 和PKDL (1%) 上发现的研究很少.
结论:
- 肯尼亚目前的莱什曼病研究需要更新,并需要解决预防,共感染和卫生系统/政策的问题.
- 对于MCL和PKDL存在重大研究缺口,需要加强关注.
- 建议紧急扩大和更新肯尼亚对这些被忽视的疾病的研究.
更多相关视频
12:22A Parasite Rescue and Transformation Assay for Antileishmanial Screening Against Intracellular Leishmania donovani Amastigotes in THP1 Human Acute Monocytic Leukemia Cell Line
Published on: December 30, 2012
22.5K
06:57In Vivo Infection with Leishmania amazonensis to Evaluate Parasite Virulence in Mice
Published on: February 20, 2020
8.3K
相关概念视频
Leishmaniasis
Leishmaniasis is a protozoal disease caused by species of the genus Leishmania and transmitted through the bite of infected female sandflies. The parasite exists in two principal morphological forms during its life cycle. A sandfly acquires intracellular amastigotes from an infected reservoir host, such as a dog. Within the sandfly, these forms differentiate into motile, flagellated promastigotes. During a subsequent blood meal, promastigotes are injected into the human host, where they...
Malaria
Malaria pathogenesis in humans reflects a delicate interplay between parasite biology and host response. Clinical illness reflects a host’s immune response to the parasite’s asexual replication cycle, which is often asymptomatic in individuals with partial immunity. From the parasite's perspective, transmission between mosquito and human with minimal host pathology is evolutionarily advantageous. Among the six Plasmodium species infecting humans, P. falciparum and P. vivax dominate in global...
Toxoplasmosis
Toxoplasmosis, a zoonotic disease caused by the protozoan Toxoplasma gondii, poses significant public health challenges globally due to its high seroprevalence and varied clinical manifestations. As an obligate intracellular parasite, T. gondii can infect all warm-blooded vertebrates, but felids are its only definitive hosts, shedding unsporulated oocysts into the environment. Humans typically acquire the infection through ingestion of tissue cysts in undercooked meat or oocysts from...
American Trypanosomiasis
Chagas disease, or American trypanosomiasis, is a vector-borne parasitic infection caused by Trypanosoma cruzi, a flagellated protozoan (kinetoplastid) of the family Trypanosomatidae. The disease is endemic in Latin America, although cases are increasingly reported worldwide due to human migration. Transmission most commonly occurs when feces of infected triatomine bugs contaminate bite wounds or mucosal surfaces; additional routes include congenital, transfusional, transplant-related, and oral...
Antiprotozoal Agents
Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...
